Boom expected in cell culture reagents
The US market for media, sera and reagents used in cell culture is expected to nearly double in value to reach $1.7 billion (€1.48bn) in 2008, according to a report.
The US market for media, sera and reagents used in cell culture is expected to nearly double in value to reach $1.7 billion (€1.48bn) in 2008, according to a report.
A new product from Emerson Process Management is enabling steam in place (SIP) cycle time reductions of typically 20 per cent on fully monitored plant installations.
Harvard Bioscience expands in Europe by acquiring UK DNA microarray and colony picking instrument firm BioRobotics for $3.2 million (€2.8m).
A production facility operated by Sigma-Aldrich was rocked by a serious explosion on Monday. There were no casualties, but the facility itself has been 'largely destroyed'.
New products unveiled as the SBS annual meeting gets underway include systems for high-throughput screening, genotyping and patch clamping.
Researchers at Merck Research Laboratories have discovered a small-molecule drug that blocks the activity of FtsZ, an emerging therapeutic target for antibacterial agents.
Switzerland's Tecan has appointed a new CEO, Aitor Galdos, four months after the abrupt departure of the former post-holder Emile Sutcliffe.